In the world
Mesenchymal stem cells are studied for the treatment of Alzheimer’s disease
In May 2017, in USA the company “Longeveron”, specializing on regenerative medicine drugs announced about the beginning of phase 1 of the clinical trial on the evaluation of the safety, tolerability and efficacy of mesenchymal stem cells in the treatment of Alzheimer’s disease.
Umbilical cord blood could ease symptoms of autism
A study observed the children over six and 12 months following the blood infusion.
Cells from umbilical cord blood have been tested as a method of treating autistic children and easing their symptoms, according to a recent study by researchers...